一种跨膜多肽通过抑制NF-κB信号通路能抑制炎症

2011-12-09 10:03 来源:丁香园 作者:重庆第三军医大学创伤、烧伤与复合伤研究国家重点实验室
字体大小
- | +

Mol Ther 2011 Oct;19(10):1849-57. [IF:7.149]

A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling.


Wang YF , Xu X , Fan X , Zhang C , Wei Q , Wang X , Guo W , Xing W , Yu J , Yan JL , Liang HP .

State Key Laboratory of Trauma, Burn and Combined Injury, Research Institute of Surgery and Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.

重庆第三军医大学创伤、烧伤与复合伤研究国家重点实验室,大坪医院野战外科研究所

Abstract

Nuclear factor-κB (NF-κB) is a central regulator of immune response and a potential target for developing anti-inflammatory agents. Mechanistic studies suggest that compounds that directly inhibit NF-κB DNA binding may block inflammation and the associated tissue damage. Thus, we attempted to discover peptides that could interfere with NF-κB signaling based on a highly conserved DNA-binding domain found in all NF-κB members. One such small peptide, designated as anti-inflammatory peptide-6 (AIP6), was characterized in the current study. AIP6 directly interacted with p65 and displayed an intrinsic cell-penetrating property. This peptide demonstrated significant anti-inflammatory effects in vitro and in vivo. In vitro, AIP6 inhibited the DNA-binding and transcriptional activities of the p65 NF-κB subunit as well as the production of inflammatory mediators in macrophages upon stimulation. Local administration of AIP6 significantly inhibited inflammation induced by zymosan in mice. Collectively, our results suggest that AIP6 is a promising lead peptide for the development of specific NF-κB inhibitors as potential anti-inflammatory agents.

编辑: lizexiu

版权声明

本网站所有注明“来源:丁香园”的文字、图片和音视频资料,版权均属于丁香园所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明“来源:丁香园”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。同时转载内容不代表本站立场。